References
- Dexter T M., Moore M. Growth and development in the haemopoietic system: the role of lymphokines and their possible therapeutic potential in disease and malignancy. Carcinogenesis 1986; 7: 509–516
- Platzer E, Cramatzki M, Kalden J. Lymphokines and monokines in the clinic. Immunol Today 1986; 7: 185–187
- Dexter M. Growth factors: From the laboratory to the clinic. Nature 1986; 321: 198
- Durant J. Immunotherapy of cancer. N Engl J Med 1987; 316: 939
- Rosenberg S, et al. A progress report on the treatment of 157 patients with advanced cancer using lymphokine-activated killer cells and interleukin-2 or high-dose interleukin-2 alone. N Engl J Med 1987; 316: 889
- West W, et al. Constant-infusion recombination interleukin-2 in adoptive immunotherapy of advanced cancer. N Engl J Med 1987; 316: 898
- Cianciolo G J., Snyderman R. Effects of tumor growth on host defenses. Cancer Metastas Rev 1986; 5: 15–27
- Moertel C G. On lymphokines, cytokines, and breakthroughs. JAMA 1986; 256: 314